Xenon Pharmaceuticals XENE FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xenon Pharmaceuticals's FX effect on cash?
- Xenon Pharmaceuticals (XENE) reported FX effect on cash of -$130K in Q1 2026.
- How has Xenon Pharmaceuticals's FX effect on cash changed year-over-year?
- Xenon Pharmaceuticals's FX effect on cash decreased by 103.1% year-over-year, from -$64K to -$130K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.